Children with cancer 'denied drugs because of EU rules'
EU rules must be changed to allow more testing of potentially life-saving cancer drugs on children, say experts.
The UK's Institute of Cancer Research (ICR) says the current system acts as a disincentive to drug companies who can seek waivers to avoid doing the trials.
Of 28 new cancer drugs approved in the EU for adults since 2007, 26 could potentially work in children, but 14 have been exempted from child testing.
The ICR wants these "class waivers" to be scrapped.
Most Popular Posts
- Healthcare Assistants wanted in Blackpool to care for a gentleman and lady with spinal injuries
- Routes Healthcare need experienced childminders across the North West of England
- Mental Health campaign receives additional funding
- Accounts & Payroll Trainee Vacancy Routes Healthcare - Macclesfield
- Social Worker Struck Off
- Routes Healthcare Blackpool is committed to the modern apprenticeship scheme
- Routes Childcare - The local company with the Worldwide experience!
- Cancer 'Smart Bomb' Successfully Tested in US
- Personalisation 'at high risk of failure', Norman Lamb told